References
1. Eiland E, Nzerue C, Faulkner M. Preeclampsia 2012. J Pregnancy2012; 2012: 586578.
2. Fox KA, Longo M, Tamayo E, Kechichian T, Bytautiene E, Hankins GD,
Saade GR, Costantine MM. Effects of pravastatin on mediators of vascular
function in a mouse model of soluble Fms-like tyrosine kinase-1-induced
preeclampsia. Am J Obstet Gynecol 2011; 205: 366 e361-365.
3. Staff AC, Braekke K, Harsem NK, Lyberg T, Holthe MR. Circulating
concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal
and maternal serum during pre-eclampsia. Eur J Obstet Gynecol
Reprod Biol 2005; 122: 33-39.
4. Yu XD, Branch DW, Karumanchi SA, Zhang J. Preeclampsia and
retinopathy of prematurity in preterm births. Pediatrics 2012;
130: e101-107.
5. Antonios TF, Raghuraman RP, D’Souza R, Nathan P, Wang D, Manyonda IT.
Capillary remodeling in infants born to hypertensive pregnancy: pilot
study. Am J Hypertens 2012; 25: 848-853.
6. Taglauer ES, Fernandez-Gonzalez A, Willis GR, Reis M, Yeung V, Liu X,
Prince LS, Mitsialis SA, Kourembanas S. Antenatal Mesenchymal Stromal
Cell Extracellular Vesicle Therapy Prevents Preeclamptic Lung Injury in
Mice. American Journal of Respiratory Cell and Molecular Biology ;
0: null.
7. Thébaud B. Preempting Bronchopulmonary Dysplasia: Time to Focus on
the Placenta? American Journal of Respiratory Cell and Molecular
Biology ; 0: null.
8. Jakkula M, Le Cras TD, Gebb S, Hirth KP, Tuder RM, Voelkel NF, Abman
SH. Inhibition of angiogenesis decreases alveolarization in the
developing rat lung. Am J Physiol Lung Cell Mol Physiol 2000;
279: L600-607.
9. Le Cras TD, Markham NE, Tuder RM, Voelkel NF, Abman SH. Treatment of
newborn rats with a VEGF receptor inhibitor causes pulmonary
hypertension and abnormal lung structure. Am J Physiol Lung Cell
Mol Physiol 2002; 283: L555-562.
10. Tang J-R, Karumanchi SA, Seedorf G, Markham N, Abman SH. Excess
soluble vascular endothelial growth factor receptor-1 in amniotic fluid
impairs lung growth in rats: linking preeclampsia with bronchopulmonary
dysplasia. American Journal of Physiology-Lung Cellular and
Molecular Physiology 2012; 302: L36-L46.
11. Yang WC, Chen CY, Chou HC, Hsieh WS, Tsao PN. Angiogenic Factors in
Cord Blood of Preterm Infants Predicts Subsequently Developing
Bronchopulmonary Dysplasia. Pediatr Neonatol 2015; 56: 382-385.
12. Mirzakhani H, Carey VJ, McElrath TF, Qiu W, Hollis BW, O’Connor GT,
Zeiger RS, Bacharier L, Litonjua AA, Weiss ST. Impact of Preeclampsia on
the Relationship between Maternal Asthma and Offspring Asthma. An
Observation from the VDAART Clinical Trial. Am J Respir Crit Care
Med 2019; 199: 32-42.
13. Stokholm J, Sevelsted A, Anderson UD, Bisgaard H. Preeclampsia
Associates with Asthma, Allergy, and Eczema in Childhood. Am J
Respir Crit Care Med 2017; 195: 614-621.
14. Hypertension in pregnancy. Report of the American College of
Obstetricians and Gynecologists’ Task Force on Hypertension in
Pregnancy. Obstet Gynecol 2013; 122: 1122-1131.
15. Castillo A, Llapur CJ, Martinez T, Kisling J, Williams-Nkomo T,
Coates C, Tepper RS. Measurement of single breath-hold carbon monoxide
diffusing capacity in healthy infants and toddlers. Pediatr
Pulmonol 2006; 41: 544-550.
16. Feher A, Castile R, Kisling J, Angelicchio C, Filbrun D, Flucke R,
Tepper R. Flow limitation in normal infants: a new method for forced
expiratory maneuvers from raised lung volumes. J Appl Physiol1996; 80: 2019-2025.
17. ATS/ERS statement: raised volume forced expirations in infants:
guidelines for current practice. Am J Respir Crit Care Med 2005;
172: 1463-1471.
18. Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin,
Number 222. Obstetrics & Gynecology 2020; 135: e237-e260.
19. Sengupta P. The Laboratory Rat: Relating Its Age With Human’s.Int J Prev Med 2013; 4: 624-630.
20. Doyle LW, Ranganathan S, Haikerwal A, Cheong JLY, Victorian Infant
Collaborative Study G. Associations of Preeclampsia with Expiratory
Airflows in School-Age Children Born Either at <28 Weeks or
Weighing <1000 g. J Pediatr 2019; 209: 39-43 e32.
21. Nixon PA, Washburn LK, O’Shea TM. Antenatal steroid exposure and
pulmonary outcomes in adolescents born with very low birth weight.Journal of Perinatology 2013; 33: 806-810.
22. Pole JD, Mustard CA, To T, Beyene J, Allen AC. Antenatal steroid
therapy for fetal lung maturation: is there an association with
childhood asthma? J Asthma 2009; 46: 47-52.
23. Martinez FD, Morgan WJ, Wright AL, Holberg CJ, Taussig LM.
Diminished lung function as a predisposing factor for wheezing
respiratory illness in infants. N Engl J Med 1988; 319:
1112-1117.
24. Balinotti JE, Chakr VC, Tiller C, Kimmel R, Coates C, Kisling J, Yu
Z, Nguyen J, Tepper RS. Growth of lung parenchyma in infants and
toddlers with chronic lung disease of infancy. Am J Respir Crit
Care Med 2010; 181: 1093-1097.
25. Fitzgerald NM, Kennedy B, Fitzgerald DA, Selvadurai H. Diffusion
capacity of carbon monoxide (DLCO) pre- and post-exercise in children in
health and disease. Pediatr Pulmonol 2014; 49: 782-789.